The clinicopathological significance of FHIT hypermethylation in non-small cell lung cancer, a meta-analysis and literature review

Emerging evidence indicates that FHIT is a candidate tumor suppressor in non-small cell lung cancer (NSCLC). However, the correlation between FHIT hypermethylation and clinicopathological characteristics of NSCLC remains unclear. Thus, we conducted a meta-analysis to quantitatively evaluate the effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Wei, Xu, Ning, Han, Xiang, Zhou, Xiao-ming, He, Bei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726317/
https://www.ncbi.nlm.nih.gov/pubmed/26796853
http://dx.doi.org/10.1038/srep19303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726317/
https://www.ncbi.nlm.nih.gov/pubmed/26796853
http://dx.doi.org/10.1038/srep19303

Ejemplares similares